Current:Home > ScamsFDA approves first postpartum depression pill-InfoLens
FDA approves first postpartum depression pill
View Date:2024-12-23 12:03:17
WASHINGTON (AP) — Federal health officials have approved the first pill specifically intended to treat severe depression after childbirth, a condition that affects thousands of new mothers in the U.S. each year.
The Food and Drug Administration on Friday granted approval of the drug, Zurzuvae, for adults experiencing severe depression related to childbirth or pregnancy. The pill is taken once a day for 14 days.
“Having access to an oral medication will be a beneficial option for many of these women coping with extreme, and sometimes life-threatening, feelings,” said Dr. Tiffany Farchione, FDA’s director of psychiatric drugs, in a statement.
Postpartum depression affects an estimated 400,000 people a year, and while it often ends on its own within a couple weeks, it can continue for months or even years. Standard treatment includes counseling or antidepressants, which can take weeks to work and don’t help everyone.
The new pill is from Sage Therapeutics, which has a similar infused drug that’s given intravenously over three days in a medical facility. The FDA approved that drug in 2019, though it isn’t widely used because of its $34,000 price tag and the logistics of administering it.
The FDA’s pill approval is based on two company studies that showed women who took Zurzuvae had fewer signs of depression over a four- to six-week period when compared with those who received a dummy pill. The benefits, measured using a psychiatric test, appeared within three days for many patients.
Sahar McMahon, 39, had never experienced depression until after the birth of her second daughter in late 2021. She agreed to enroll in a study of the drug, known chemically as zuranolone, after realizing she no longer wanted to spend time with her children.
“I planned my pregnancies, I knew I wanted those kids but I didn’t want to interact with them,” said McMahon, who lives in New York City. She says her mood and outlook started improving within days of taking the first pills.
“It was a quick transition for me just waking up and starting to feel like myself again,” she said.
Dr. Kimberly Yonkers of Yale University said the Zurzuvae effect is “strong” and the drug likely will be prescribed for women who haven’t responded to antidepressants. She wasn’t involved in testing the drug.
Still, she said, the FDA should have required Sage to submit more follow-up data on how women fared after additional months.
“The problem is we don’t know what happens after 45 days,” said Yonkers, a psychiatrist who specializes in postpartum depression. “It could be that people are well or it could be that they relapse.”
Sage did not immediately announce how it would price the pill, and Yonkers said that’ll be a key factor in how widely its prescribed.
Side effects with the new drug are milder than the IV version, and include drowsiness and dizziness. The drug was co-developed with fellow Massachusetts pharmaceutical company Biogen.
Both the pill and IV forms mimic a derivative of progesterone, the naturally occurring female hormone needed to maintain a pregnancy. Levels of the hormone can plunge after childbirth.
Sage’s drugs are part of an emerging class of medications dubbed neurosteroids. These stimulate a different brain pathway than older antidepressants that target serotonin, the chemical linked to mood and emotions.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.
veryGood! (42)
Related
- Garth Brooks wants to move his sexual assault case to federal court. How that could help the singer.
- Margot Robbie Is Saying Sul Sul to The Sims Movie
- Democratic senators push bill focusing on local detainment of immigrants linked to violent crime
- 'The spirits are still there': Old 'Ghostbusters' gang is back together in 'Frozen Empire'
- Tennessee fugitive accused of killing a man and lying about a bear chase is caught in South Carolina
- Final ex-Mississippi 'Goon Squad' officer sentenced to 10 years in torture of 2 Black men
- Bus hijacked in downtown Los Angeles collides with several vehicles and crashes into a hotel
- Create a digital will or control what Meta shares with savvy tech tips
- Certifying this year’s presidential results begins quietly, in contrast to the 2020 election
- Garland dismisses criticism that he should have altered Hur report as absurd
Ranking
- Special counsel Smith asks court to pause appeal seeking to revive Trump’s classified documents case
- What is spiritual narcissism? These narcissists are at your church, yoga class and more
- Post Malone teases country collaboration with Morgan Wallen: 'Let's go with the real mix'
- State Farm discontinuing 72,000 home policies in California in latest blow to state insurance market
- Powerball winning numbers for Nov. 9 drawing: Jackpot rises to $92 million
- Get a Bag From Shay Mitchell’s BÉIS for Just $70, 50% Off Too Faced Better Than Sex Mascara & More Deals
- A Nashville guide for those brought here by Beyoncé: Visit these Music City gems
- Sara Evans, husband Jay Barker have reconciled after his 2022 arrest: 'We're so happy now'
Recommendation
-
Kathy Bates likes 'not having breasts' after her cancer battle: 'They were like 10 pounds'
-
Activists rally for bill that would allow some Alabama death row inmates to be resentenced
-
Duke's Caleb Foster shuts it down ahead of NCAA Tournament
-
Human composting as alternative to burial and cremation gets final approval by Delaware lawmakers
-
DWTS' Gleb Savchenko Shares Why He Ended Brooks Nader Romance Through Text Message
-
What is Oakland coach Greg Kampe's bonus after his team's upset of Kentucky? It's complicated
-
Sen. Bob Menendez won't run in N.J. Democratic primary, may seek reelection as independent if cleared in bribery case
-
Richard Higgins, one of the last remaining survivors of Pearl Harbor attack, dies at 102